An action plan has been drawn up to tackle issues including drugs and overcrowding at a South Yorkshire prison.

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

Because diet culture is often disguised as concern for health, discipline or self-improvement, it can be especially difficult ...

Just a few days before Christmas, about thirty ambassadors were recalled from their posts over vague accusations of ...

More updates on the case are expected in the coming hours, which will determine how these funding changes will impact the ...

The battle for dominance in medical AI has escalated rapidly. Just days after OpenAI grabbed headlines with the debut of ...

President Trump welcomed the oil executives to the White House after US forces earlier Friday seized their fifth tanker over ...

Diagnoses of depression, one of the most common mental disorders, increased by nearly 50% between 1990 and 2017, according to data from the World ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

Research efforts are ongoing to develop safer, broad-spectrum antivenoms. Technology Networks sat down with Dr. Andreas ...

Common preservatives used to keep food safe and extend shelf life may be linked to a higher risk of several cancers and type ...